Lv51
930 积分 2025-01-06 加入
Tunlametinib: First Approval
16天前
已完结
Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy
21天前
已完结
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
22天前
已完结
Membranous nephropathy
1个月前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
1个月前
已完结
Rituximab and chlorambucil versus rituximab alone in gastric mucosa-associated lymphoid tissue lymphoma according to t(11;18) status: a monocentric non-randomized observational study
1个月前
已关闭
Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial
1个月前
已完结
Ryzneuta for Prevention of Febrile Neutropenia
2个月前
已关闭
Clinical and pathological predictors for FDG-PET/CT avidity in patients with marginal zone lymphoma—a retrospective cohort study
2个月前
已完结
Efbemalenograstim Alfa: First Approval
3个月前
已完结
皖公网安备34019202002308
